AgingResearch.NewsJoin free

Orient Pharma

Organization

Trials

  • NCT04643093

    Phase 3, Completed, 390 people, Nov 24, 2020

  • NCT01710007

    Phase 3, Completed, 202 people, Oct 18, 2012